FOUR DRUGS, DIFFERENT HEALTH QUESTIONS
Which evidence fits the benefit you’re asking about?
Studies measured belly fat, weight, serious illness, or eating after surgery. Those aren’t the same health questions. To compare, you need who took part and the changes found.
Why can’t you rank these drugs for every problem?
Trials measured different problems, rather than one shared test of health. Adults living with HIV lost unusual deep belly fat with tesamorelin, its approved use. Semaglutide copies GLP-1, the gut hormone message concerning hunger and blood sugar. Large trials measured weight lost and cases of serious illness.
After surgery, ipamorelin failed to prove useful recovery despite its growth hormone effects [15]. Its hormone message differs from tesamorelin's, and it has no approval. BPC-157 healing findings mainly concern animals and laboratory cells [19][21][22]. You can't treat that work as equally strong human evidence.
FDA approval tells you which medicine passed review for which use. Pharmacy rules concern when a pharmacy may make a drug. Studies ask whether people gained a benefit. One answer doesn't settle the other questions for you.
A drug can act on the body without showing useful benefit. Your proposed use might lack approval. Comparing these drugs is like comparing tools for different jobs. First, name the health problem you want the evidence to answer.
What is each drug’s strongest evidence in people?
| Drug | What the drug does | Strongest human tests | FDA approval | Questions still open for you |
|---|---|---|---|---|
| Tesamorelin | causes more growth hormone release | separate trials found that adults living with HIV lost deep belly fat [1][3][5][6] | one specific use | benefits for other people and risks over years |
| Semaglutide | copies GLP-1, a hormone message concerning hunger and blood sugar | large weight, heart, and kidney studies [9][10][11] | certain uses | side effects and quality of versions outside approved medicines |
| Ipamorelin | changes growth hormone through a different hormone message | failed bowel recovery test and brief hormone studies [15][16] | no approved use | lasting safety and proven health benefit |
| BPC-157 | might help blood vessels grow | very small human tests, mostly animal or laboratory findings [18][19][21][22] | no approved use | most benefits and risks in people |
The drugs have different amounts of human proof. A benefit trial answers questions a tiny safety test can't. You need the kind of test that matches the benefit promised.
What if someone offers you a drug without approval?
Tesamorelin and semaglutide have approved products for stated uses. Ipamorelin and BPC-157 don't have drug approval. A seller's wording can't change those facts. Neither can a new label on an unapproved vial.
Approval doesn't permit broad advertising for uses outside the approved ones. A seller might promise you a benefit that hasn't passed review. Pharmacies follow separate legal rules when they make drugs. Those preparations don't receive FDA's review as approved medicines before sale.
A shortage can affect what a pharmacy is allowed to make. Temporary access doesn't supply drug approval or missing studies. First, ask which product, use, and people the promise concerns.
What can this evidence leave unanswered about your care?
These drugs aren't interchangeable treatments for your health problem. Studies can't decide your personal treatment from this comparison. Products outside drug rules still have uncertain contents and cleanliness. A promise from the seller doesn't settle quality for you.
Sleep, appetite, and healing reports are experiences from people using drugs for research outside comparison trials, which studies haven't confirmed. People's enthusiasm can't measure your chance of benefit. A report can suggest a question for future testing. The cause still needs a treatment comparison.
Semaglutide trials measured pounds lost and cases of serious illness in large groups. Tesamorelin's evidence concerns unusual fat build-up in people living with HIV. Ipamorelin has short hormone tests and a failed surgery trial. BPC-157 mostly has animal work, with very little human testing.